trastuzumab-anns 150 MG Injection [Kanjinti]
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
trastuzumab-anns 150 MG Injection [Kanjinti]
150 MG · Injection · injection
A form of trastuzumab-anns →
trastuzumab-anns 150 MG Injection [Kanjinti] — HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Strength, form, class, interactions & more.
![trastuzumab-anns 150 MG Injection [Kanjinti]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9a94f5b2-b84e-4987-8ea1-c4346db5a5fa&name=kanjinti-01.jpg)
Active ingredient
Classification
HER2 (Human Epidermal Growth Factor Receptor 2) inhibitorsHER2/neu Receptor Antagonist
Drug interactions
Trastuzumab-anns may interact with anthracyclines, leading to increased risk of cardiac dysfunction.
- majoranthracyclines — increased risk of cardiac dysfunction
- moderateanthracyclines — requires close monitoring of cardiac function
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication